BlueCrest Capital Management’s Calumet Specialty Products CLMT Stock Holding History

BlueCrest Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Buy	80,000 +20,000	+33%	+$672K	0.09%	137
2026 Q1	$2.15M	Buy	60,000 +20,000	+50%	+$518K	0.13%	142
2025 Q4	$795K	Sell	40,000 -20,000	-33%	-$385K	0.02%	139
2025 Q3	$1.09M	Buy	60,000 +12,000	+25%	+$197K	0.02%	146
2025 Q2	$756K	Sell	48,000 -22,000	-31%	-$280K	0.03%	95
2025 Q1	$888K	Buy	70,000 +20,000	+40%	+$314K	0.04%	60
2024 Q4	$1.1M	Buy	50,000 +10,000	+25%	+$210K	0.03%	73
2024 Q3	$713K	Buy	+40,000	New	+$641K	0.04%	62

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlueCrest Capital Management's CLMT Position: Q2 2026 in Review

BlueCrest Capital Management increased its Calumet Specialty Products (CLMT) stake by 33% in Q2 2026, buying an estimated $672K and bringing the position to 80,000 shares worth $2.88M. The position accounts for 0.09% of the portfolio, ranked #137.

BlueCrest Capital Management first reported a position in CLMT in Q3 2024 and has held it in 8 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

BlueCrest Capital Management held 80,000 shares of Calumet Specialty Products worth $2.88M as of Q2 2026.
BlueCrest Capital Management bought 20,000 Calumet Specialty Products shares in Q2 2026, an estimated $672K.
Calumet Specialty Products made up 0.09% of BlueCrest Capital Management's portfolio in Q2 2026, its #137 holding.
BlueCrest Capital Management first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 8 quarters since.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on BlueCrest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.